| Year |
Citation |
Score |
| 2022 |
Biondetti E, Karsa A, Grussu F, Battiston M, Yiannakas MC, Thomas DL, Shmueli K. Multi-echo quantitative susceptibility mapping: how to combine echoes for accuracy and precision at 3 Tesla. Magnetic Resonance in Medicine. PMID 35766450 DOI: 10.1002/mrm.29365 |
0.755 |
|
| 2021 |
Berg RC, Preibisch C, Thomas DL, Shmueli K, Biondetti E. Investigating the Effect of Flow Compensation and Quantitative Susceptibility Mapping Method on the Accuracy of Venous Susceptibility Measurement. Neuroimage. 118399. PMID 34273528 DOI: 10.1016/j.neuroimage.2021.118399 |
0.755 |
|
| 2020 |
Falade-Nwulia O, Gicquelais RE, Astemborski J, McCormick SD, Kirk G, Sulkowski M, Thomas DL, Mehta SH. Hepatitis C Treatment Uptake among People who Inject Drugs in the Oral Direct-Acting Antiviral Era. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 32770638 DOI: 10.1111/Liv.14634 |
0.389 |
|
| 2020 |
Thomas DL. State of the Hepatitis C Virus Care Cascade. Clinical Liver Disease. 16: 8-11. PMID 32714516 DOI: 10.1002/Cld.915 |
0.312 |
|
| 2020 |
Irvin R, Ntiri-Reid B, Kleinman M, Agee T, Hitt J, Anaedozie O, Arowolo T, Cassidy-Stewart H, Bush C, Wilson LE, Millman AJ, Nelson NP, Canary L, Brinkley S, Moon J, ... ... Thomas DL, et al. Sharing the Cure: Building Primary Care and Public Health Infrastructure to Improve the Hepatitis C Care Continuum in Maryland. Journal of Viral Hepatitis. PMID 32671942 DOI: 10.1111/Jvh.13360 |
0.369 |
|
| 2020 |
Biondetti E, Karsa A, Thomas DL, Shmueli K. Investigating the accuracy and precision of TE-dependent versus multi-echo QSM using Laplacian-based methods at 3 T. Magnetic Resonance in Medicine. PMID 32491224 DOI: 10.1002/Mrm.28331 |
0.757 |
|
| 2020 |
Verma M, Chu JN, Salama JAF, Faiz MT, Eweje F, Gwynne D, Lopes A, Hess K, Soares V, Steiger C, McManus R, Koeppen R, Hua T, Hayward A, Collins J, ... ... Thomas DL, et al. Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine. Proceedings of the National Academy of Sciences of the United States of America. PMID 32424082 DOI: 10.1073/Pnas.2004746117 |
0.365 |
|
| 2020 |
Boon D, Bruce V, Patel EU, Quinn J, Srikrishnan AK, Shanmugam S, Iqbal S, Balakrishnan P, Sievers M, Kirk GD, Thomas DL, Quinn TC, Cox AL, Page KA, Solomon SS, et al. Antibody avidity-based approach to estimate population-level incidence of hepatitis C. Journal of Hepatology. PMID 32240715 DOI: 10.1016/J.Jhep.2020.03.028 |
0.375 |
|
| 2020 |
Falade-Nwulia O, Sacamano P, McCormick SD, Yang C, Kirk G, Thomas D, Sulkowski M, Latkin C, Mehta SH. Individual and network factors associated with HCV treatment uptake among people who inject drugs. The International Journal On Drug Policy. 78: 102714. PMID 32135398 DOI: 10.1016/J.Drugpo.2020.102714 |
0.375 |
|
| 2020 |
Falade-Nwulia O, Ward KM, McCormick S, Mehta SH, Pitts SR, Katz S, Chander G, Thomas DL, Sulkowski M, Latkin CA. Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care. Journal of Viral Hepatitis. PMID 32045086 DOI: 10.1111/Jvh.13274 |
0.374 |
|
| 2020 |
Clipman SJ, Duggal P, Srikrishnan AK, Saravanan S, Balakrishnan P, Vasudevan CK, Celentano DD, Thomas DL, Mehta SH, Solomon SS. Prevalence and phylogenetic characterization of hepatitis C among men who have sex with men in India: limited evidence for sexual transmission. The Journal of Infectious Diseases. PMID 31917837 DOI: 10.1093/Infdis/Jiaa006 |
0.343 |
|
| 2020 |
Verma M, Chu JN, Salama JA, Faiz MT, Gwynne FED, Lopes A, Hess K, Soares V, Steiger C, McManus R, Koeppen R, Hua T, Hayward A, Collins JE, Tamang S, ... ... Thomas DL, et al. Sa1527 DEVELOPMENT OF A LONG-ACTING DIRECT-ACTING ANTIVIRAL SYSTEM FOR HEPATITIS C VIRUS TREATMENT IN A SWINE MODEL Gastroenterology. 158. DOI: 10.1016/S0016-5085(20)33972-X |
0.334 |
|
| 2019 |
Bollinger RC, Thio CL, Sulkowski MS, McKenzie-White J, Thomas DL, Flexner C. Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV. The Lancet. Hiv. PMID 31870675 DOI: 10.1016/S2352-3018(19)30342-X |
0.309 |
|
| 2019 |
Irvin R, Chander G, Ward KM, Manogue S, Falade-Nwulia O, Moon J, Sutcliffe CG, Brinkley S, Haselhuhn T, Katz S, Herne K, Arteaga L, Thomas DL, Mehta SH, Sulkowski MS. Unreported Alcohol Use Was Common But Did Not Impact Hepatitis C Cure in HIV-Infected Persons Who Use Drugs. Journal of Viral Hepatitis. PMID 31854069 DOI: 10.1111/Jvh.13251 |
0.351 |
|
| 2019 |
Hackman J, Falade-Nwulia O, Patel EU, Mehta SH, Kirk GD, Astemborski J, Ray SC, Thomas DL, Laeyendecker O. Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 104078. PMID 31669367 DOI: 10.1016/J.Meegid.2019.104078 |
0.314 |
|
| 2019 |
Falade-Nwulia O, Sutcliffe CG, Mehta SH, Moon J, Chander G, Keruly J, Katzianer J, Thomas DL, Moore RD, Sulkowski MS. Hepatitis C Elimination in People With HIV Is Contingent on Closing Gaps in the HIV Continuum. Open Forum Infectious Diseases. 6: ofz426. PMID 31667200 DOI: 10.1093/Ofid/Ofz426 |
0.382 |
|
| 2019 |
Sherman KE, Peters MG, Thomas DL. HIV and the liver. Topics in Antiviral Medicine. 27: 101-110. PMID 31634861 DOI: 10.1002/9781444341294.Ch22 |
0.343 |
|
| 2019 |
Suhas Solomon S, Quinn TC, Solomon S, McFall AM, Srikrishnan AK, Verma V, Kumar MS, Laeyendecker O, Celentano DD, Iqbal SH, Anand S, Vasudevan CK, Saravanan S, Thomas DL, Singh Sachdeva K, et al. Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial. Journal of Hepatology. PMID 31604081 DOI: 10.1016/J.Jhep.2019.09.022 |
0.335 |
|
| 2019 |
Thomas DL. Global Elimination of Chronic Hepatitis. The New England Journal of Medicine. 380: 2041-2050. PMID 31116920 DOI: 10.1056/Nejmra1810477 |
0.32 |
|
| 2019 |
Biondetti E, Rojas-Villabona A, Sokolska M, Pizzini FB, Jäger HR, Thomas DL, Shmueli K. Investigating the oxygenation of brain arteriovenous malformations using quantitative susceptibility mapping. Neuroimage. PMID 31075392 DOI: 10.1016/J.Neuroimage.2019.05.014 |
0.763 |
|
| 2019 |
Irvin R, Chander G, Falade-Nwulia O, Astemborski J, Starbird L, Kirk GD, Sulkowski MS, Thomas DL, Mehta SH. Overlapping epidemics of alcohol and illicit drug use among HCV-infected persons who inject drugs. Addictive Behaviors. 96: 56-61. PMID 31035079 DOI: 10.1016/J.Addbeh.2019.04.023 |
0.374 |
|
| 2019 |
Falade-Nwulia O, Irvin R, Merkow A, Sulkowski M, Niculescu A, Olsen Y, Stoller K, Thomas DL, Latkin C, Mehta SH. Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore. Journal of Substance Abuse Treatment. 100: 45-51. PMID 30898327 DOI: 10.1016/J.Jsat.2019.01.021 |
0.382 |
|
| 2019 |
Rose R, Rodriguez C, Dollar JJ, Lamers SL, Massaccesi G, Osburn W, Ray SC, Thomas DL, Cox AL, Laeyendecker O. Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. PMID 30802530 DOI: 10.1016/J.Meegid.2019.02.025 |
0.37 |
|
| 2019 |
Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, Dusheiko G, Feld JJ, Gore C, Griswold MG, Hamid S, Hellard ME, Hou J, Howell J, Jia J, ... ... Thomas DL, et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. The Lancet. Gastroenterology & Hepatology. 4: 135-184. PMID 30647010 DOI: 10.1016/S2468-1253(18)30270-X |
0.354 |
|
| 2019 |
Patel EU, Thio CL, Boon D, Thomas DL, Tobian AAR. Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30605508 DOI: 10.1093/Cid/Ciz001 |
0.348 |
|
| 2019 |
Falade-Nwulia O, Hackman J, Mehta S, Sulkowski M, Latkin C, Thomas D, Downing Z, Latanich R, Kirk G, Laeyendecker O, Ray S. A22 Phylogenetic clustering of hepatitis C virus infection among people who inject drugs in Baltimore Virus Evolution. 5. DOI: 10.1093/Ve/Vez002.021 |
0.392 |
|
| 2018 |
Vergara C, Thio CL, Johnson E, Kral AH, O'Brien TR, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, Peters MG, ... ... Thomas DL, et al. Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. Gastroenterology. PMID 30593799 DOI: 10.1053/J.Gastro.2018.12.014 |
0.403 |
|
| 2018 |
Finnerty E, Ramasawmy R, O'Callaghan J, Connell JJ, Lythgoe M, Shmueli K, Thomas DL, Walker-Samuel S. Noninvasive quantification of oxygen saturation in the portal and hepatic veins in healthy mice and those with colorectal liver metastases using QSM MRI. Magnetic Resonance in Medicine. PMID 30450573 DOI: 10.1002/Mrm.27571 |
0.669 |
|
| 2018 |
Hsieh YH, Signer D, Patel AV, Viertel V, Saheed M, Irvin R, Sulkowski MS, Thomas DL, Rothman RE. Advanced liver fibrosis and care continuum in emergency department patients with chronic hepatitis C. The American Journal of Emergency Medicine. PMID 30409463 DOI: 10.1016/J.Ajem.2018.08.067 |
0.362 |
|
| 2018 |
Flexner C, Thomas DL, Swindells S. Creating demand for long-acting formulations for the treatment and prevention of HIV, tuberculosis, and viral hepatitis. Current Opinion in Hiv and Aids. PMID 30394948 DOI: 10.1097/Coh.0000000000000510 |
0.31 |
|
| 2018 |
Irvin R, Ward K, Agee T, Nelson NP, Vellozzi C, Thomas DL, Millman AJ. Comparison of hepatitis C virus testing recommendations in high-income countries. World Journal of Hepatology. 10: 743-751. PMID 30386467 DOI: 10.4254/Wjh.V10.I10.743 |
0.368 |
|
| 2018 |
Patel EU, Mehta SH, Boon D, Quinn TC, Thomas DL, Tobian AAR. Limited Coverage of Hepatitis C Virus Testing in the United States, 2013-2017. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30239645 DOI: 10.1093/Cid/Ciy803 |
0.323 |
|
| 2018 |
Shin DJ, Trick AY, Hsieh YH, Thomas DL, Wang TH. Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation. Scientific Reports. 8: 9793. PMID 29955160 DOI: 10.1038/S41598-018-28124-3 |
0.316 |
|
| 2018 |
Hsieh YH, Patel AV, Loevinsohn GS, Thomas DL, Rothman RE. Emergency Departments at the Crossroads of Intersecting Epidemics (HIV, HCV, Injection Drug Use, and Opioid Overdose) - Estimating HCV Incidence in an Urban Emergency Department Population. Journal of Viral Hepatitis. PMID 29888842 DOI: 10.1111/Jvh.12948 |
0.375 |
|
| 2018 |
Patel EU, Solomon SS, Mcfall AM, Srikrishnan AK, Pradeep A, Nandagopal P, Laeyendecker O, Tobian AAR, Thomas DL, Sulkowski MS, Kumar MS, Mehta SH. Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India. The International Journal On Drug Policy. 57: 51-60. PMID 29679811 DOI: 10.1016/J.Drugpo.2018.03.023 |
0.371 |
|
| 2018 |
Irvin R, McAdams-Mahmoud A, White J, Grant Z, Falade-Nwulia O, Sherman S, Beyrer C, Sulkowski M, Thomas DL, Mehta SH, Chaisson R. An Education and Field Experience Program to Increase Detection of Human Immunodeficiency Virus and Hepatitis C Virus. Progress in Community Health Partnerships : Research, Education, and Action. 12: 101-109. PMID 29606698 DOI: 10.1353/Cpr.2018.0011 |
0.384 |
|
| 2017 |
Huang H, Duggal P, Thio CL, Latanich R, Goedert JJ, Mangia A, Cox AL, Kirk GD, Mehta S, Aneja J, Alric L, Donfield SM, Cramp ME, Khakoo SI, Tobler LH, ... ... Thomas DL, et al. Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection. Scientific Reports. 7: 15843. PMID 29158528 DOI: 10.1038/S41598-017-16011-2 |
0.386 |
|
| 2017 |
Solomon SS, Sulkowski MS, Amrose P, Srikrishnan AK, McFall AM, Ramasamy B, Kumar MS, Anand S, Thomas DL, Mehta SH. Directly Observed Therapy of Sofosbuvir/Ribavirin +/- Peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT). Journal of Viral Hepatitis. PMID 28719029 DOI: 10.1111/Jvh.12761 |
0.339 |
|
| 2017 |
Falade-Nwulia O, Sutcliffe C, Moon J, Chander G, Wansom T, Keruly J, Katzianer J, Nathanson A, Marks J, Mehta S, Thomas D, Moore R, Sulkowski M. High Hepatitis C cure rates among black and non-black HIV-infected adults in an urban center. Hepatology (Baltimore, Md.). PMID 28608973 DOI: 10.1002/Hep.29308 |
0.393 |
|
| 2017 |
Lazo M, Nwankwo C, Daya NR, Thomas DL, Mehta SH, Juraschek S, Willis K, Selvin E. Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 28579183 DOI: 10.1016/J.Cgh.2017.04.046 |
0.303 |
|
| 2017 |
Wansom T, Falade-Nwulia O, Sutcliffe CG, Mehta SH, Moore RD, Thomas DL, Sulkowski MS. Barriers to Hepatitis C Virus (HCV) Treatment Initiation in Patients With Human Immunodeficiency Virus/HCV Coinfection: Lessons From the Interferon Era. Open Forum Infectious Diseases. 4: ofx024. PMID 28480293 DOI: 10.1093/Ofid/Ofx024 |
0.414 |
|
| 2017 |
Talal AH, Thomas DL, Reynolds JL, Khalsa JH. Toward Optimal Control of Hepatitis C Virus Infection in Persons With Substance Use Disorders. Annals of Internal Medicine. PMID 28437796 DOI: 10.7326/M16-2887 |
0.382 |
|
| 2017 |
Cepeda JA, Thomas DL, Astemborski J, Sulkowski MS, Kirk GD, Mehta SH. Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28329108 DOI: 10.1093/Cid/Cix207 |
0.377 |
|
| 2017 |
Vergara C, Thio C, Latanich R, Cox AL, Kirk GD, Mehta SH, Busch M, Murphy EL, Villacres MC, Peters MG, French AL, Golub E, Eron J, Lahiri CD, Shrestha S, ... ... Thomas DL, et al. Genetic basis for variation in plasma IL-18 levels in persons with chronic hepatitis C virus and human immunodeficiency virus-1 infections. Genes and Immunity. PMID 28300059 DOI: 10.1038/Gene.2017.2 |
0.355 |
|
| 2017 |
Seremba E, Ssempijja V, Kalibbala S, Gray RH, Wawer MJ, Nalugoda F, Casper C, Phipps WT, Ocama P, Serwadda D, Thomas DL, Reynolds S. Hepatitis B incidence and prevention with antiretroviral therapy among HIV positive individuals in Rakai, Uganda. Aids (London, England). PMID 28099188 DOI: 10.1097/Qad.0000000000001399 |
0.344 |
|
| 2017 |
Patel A, Rothman R, Thomas D, Hsieh Y. High Incidence of Hepatitis C Virus (HCV) Infection among an Urban Emergency Department (ED) Patients. 2003–2016. Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.371 |
0.4 |
|
| 2017 |
Sulkowski M, Ward K, Falade-Nwulia O, Moon J, Sutcliffe C, Brinkley S, Haselhuhn T, Thomas D, Katz S, Herne K, Arteaga L, Mehta S. Randomized controlled trial of cash incentives or peer mentors to improve HCV linkage and treatment among HIV/HCV coinfected persons who inject drugs: the CHAMPS Study Journal of Hepatology. 66: S719. DOI: 10.1016/S0168-8278(17)31922-0 |
0.366 |
|
| 2016 |
Cepeda JA, Solomon SS, Srikrishnan AK, Nandagopal P, Balakrishnan P, Kumar MS, Thomas DL, Sulkowski MS, Mehta SH. Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India. Open Forum Infectious Diseases. 3: ofw156. PMID 27704012 DOI: 10.1093/Ofid/Ofw156 |
0.384 |
|
| 2016 |
Naggie S, Holland D, Sulkowski MS, Thomas DL. HCV post-exposure prophylaxis in the healthcare worker: Why DAAs don't change a thing. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27682067 DOI: 10.1093/Cid/Ciw656 |
0.361 |
|
| 2016 |
Mehta SH, McFall AM, Srikrishnan AK, Kumar MS, Nandagopal P, Cepeda J, Thomas DL, Sulkowski MS, Solomon SS. Morbidity and Mortality Among Community-Based People Who Inject Drugs With a High Hepatitis C and Human Immunodeficiency Virus Burden in Chennai, India. Open Forum Infectious Diseases. 3: ofw121. PMID 27419185 DOI: 10.1093/Ofid/Ofw121 |
0.409 |
|
| 2016 |
Mehta SH, Thomas DL. Doing the math on hepatitis C virus treatment. Journal of Hepatology. PMID 27050632 DOI: 10.1016/J.Jhep.2016.03.015 |
0.414 |
|
| 2016 |
Hsieh YH, Rothman RE, Laeyendecker OB, Kelen GD, Avornu A, Patel EU, Kim J, Irvin R, Thomas DL, Quinn TC. Evaluation of The CDC Recommendations for HCV Testing in an Urban Emergency Department. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26908800 DOI: 10.1093/Cid/Ciw074 |
0.384 |
|
| 2016 |
Falade-Nwulia O, Irvin R, McAdams-Mahmoud A, Mehta SH, Niculescu A, Lasola J, Baker D, Eppel A, Chaulk P, Page KR, Sulkowski M, Thomas D. Senior Center-Based Hepatitis C Screening in Baltimore. Open Forum Infectious Diseases. 3: ofv217. PMID 26885546 DOI: 10.1093/Ofid/Ofv217 |
0.405 |
|
| 2016 |
Falade-Nwulia O, Mehta SH, Lasola J, Latkin C, Niculescu A, O'Connor C, Chaulk P, Ghanem K, Page KR, Sulkowski MS, Thomas DL. Public health clinic-based hepatitis C testing and linkage to care in baltimore. Journal of Viral Hepatitis. 23: 366-74. PMID 26840570 DOI: 10.1111/Jvh.12507 |
0.384 |
|
| 2016 |
Solomon SS, Srikrishnan AK, McFall AM, Kumar MS, Saravanan S, Balakrishnan P, Solomon S, Thomas DL, Sulkowski MS, Mehta SH. Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India. Plos One. 11: e0147879. PMID 26812065 DOI: 10.1371/Journal.Pone.0147879 |
0.341 |
|
| 2016 |
Patel EU, Cox AL, Mehta SH, Boon D, Mullis CE, Astemborski J, Osburn WO, Quinn J, Redd AD, Kirk GD, Thomas DL, Quinn TC, Laeyendecker O. Hepatitis C IgG antibody avidity as a biomarker to estimate population-level incidence. The Journal of Infectious Diseases. PMID 26768250 DOI: 10.1093/Infdis/Jiw005 |
0.367 |
|
| 2016 |
Seremba E, Ssempijja V, Kalibbala S, Gray R, Wawer M, Nalugoda F, Casper C, Phipps WT, Ocama P, Thomas DL, Reynolds SJ. Antiretroviral Therapy is Highly Effective Against Incident Hepatitis B Disease Acquisition Among HIV-Infected Adults in Rakai, Uganda Journal of Global Oncology. 2: 62s-63s. DOI: 10.1200/Jgo.2016.004044 |
0.348 |
|
| 2015 |
Hiramine S, Sugiyama M, Furusyo N, Uto H, Ido A, Tsubouchi H, Watanabe H, Ueno Y, Korenaga M, Murata K, Masaki N, Hayashi J, Thomas DL, Mizokami M. Erratum to: A thymine-adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus. Journal of Gastroenterology. PMID 26705759 DOI: 10.1007/S00535-015-1155-Z |
0.346 |
|
| 2015 |
Sherman KE, Rockstroh J, Thomas D. Human immunodeficiency virus and liver disease: An update. Hepatology (Baltimore, Md.). PMID 26340591 DOI: 10.1002/Hep.28150 |
0.357 |
|
| 2015 |
O'Brien TR, Pfeiffer RM, Paquin A, Lang Kuhs KA, Chen S, Bonkovsky HL, Edlin BR, Howell CD, Kirk GD, Kuniholm MH, Morgan TR, Strickler HD, Thomas DL, Prokunina-Olsson L. Comparison of Functional Variants in IFNL4 and IFNL3 for Association with Hepatitis C Virus Clearance. Journal of Hepatology. PMID 26186989 DOI: 10.1016/J.Jhep.2015.06.035 |
0.365 |
|
| 2015 |
El-Diwany R, Wasilewski L, Witwer KW, Bailey JR, Page K, Ray SC, Cox AL, Thomas DL, Balagopal A. Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating miRNAs that are Associated with Non-Lytic Hepatocyte Release. Journal of Virology. PMID 26157120 DOI: 10.1128/Jvi.00955-15 |
0.331 |
|
| 2015 |
Kurbanov F, Kim Y, Latanich R, Chaudhari P, El-Diwany R, Knabel M, Kandathil AJ, Cameron A, Cox A, Jang YY, Thomas DL, Balagopal A. IFNL3 genotype is associated with differential induction of IFNL3 in primary human hepatocytes. Antiviral Therapy. PMID 26109548 DOI: 10.3851/Imp2974 |
0.363 |
|
| 2015 |
Bailey JR, Dowd KA, Snider AE, Osburn WO, Mehta SH, Kirk GD, Thomas DL, Ray SC. CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus. The Journal of Infectious Diseases. PMID 25754978 DOI: 10.1093/Infdis/Jiv139 |
0.415 |
|
| 2015 |
Hiramine S, Sugiyama M, Furusyo N, Uto H, Ido A, Tsubouchi H, Watanabe H, Ueno Y, Korenaga M, Murata K, Masaki N, Hayashi J, Thomas DL, Mizokami M. A thymine-adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus. Journal of Gastroenterology. PMID 25735432 DOI: 10.1007/S00535-015-1056-1 |
0.387 |
|
| 2015 |
Ray SC, Thomas DL. 156 – Hepatitis C Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 1904-1927. DOI: 10.1016/B978-1-4557-4801-3.00156-9 |
0.331 |
|
| 2014 |
Graw F, Balagopal A, Kandathil AJ, Ray SC, Thomas DL, Ribeiro RM, Perelson AS. Inferring viral dynamics in chronically HCV infected patients from the spatial distribution of infected hepatocytes. Plos Computational Biology. 10: e1003934. PMID 25393308 DOI: 10.1371/Journal.Pcbi.1003934 |
0.38 |
|
| 2014 |
Zignego AL, Wojcik GL, Cacoub P, Visentini M, Casato M, Mangia A, Latanich R, Charles ED, Gragnani L, Terrier B, Piazzola V, Dustin LB, Khakoo SI, Busch MP, Lauer GM, ... ... Thomas DL, et al. Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis. Genes and Immunity. 15: 500-5. PMID 25030430 DOI: 10.1038/Gene.2014.41 |
0.324 |
|
| 2014 |
Balagopal A, Kandathil AJ, Higgins YH, Wood J, Richer J, Quinn J, Eldred L, Li Z, Ray SC, Sulkowski MS, Thomas DL. Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients. Hepatology (Baltimore, Md.). 60: 477-86. PMID 24706559 DOI: 10.1002/Hep.27158 |
0.399 |
|
| 2014 |
Thomas DL. A case for ribavirin to treat chronic hepatitis E. The New England Journal of Medicine. 370: 1162-3. PMID 24645951 DOI: 10.1056/Nejme1401440 |
0.377 |
|
| 2014 |
Wojcik GL, Thio CL, Kao WH, Latanich R, Goedert JJ, Mehta SH, Kirk GD, Peters MG, Cox AL, Kim AY, Chung RT, Thomas DL, Duggal P. Admixture analysis of spontaneous hepatitis C virus clearance in individuals of African descent. Genes and Immunity. 15: 241-6. PMID 24622687 DOI: 10.1038/Gene.2014.11 |
0.379 |
|
| 2014 |
Konerman MA, Mehta SH, Sutcliffe CG, Vu T, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS. Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs. Hepatology (Baltimore, Md.). 59: 767-75. PMID 24436062 DOI: 10.1002/Hep.26741 |
0.396 |
|
| 2014 |
Osburn WO, Snider AE, Wells BL, Latanich R, Bailey JR, Thomas DL, Cox AL, Ray SC. Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses. Hepatology (Baltimore, Md.). 59: 2140-51. PMID 24425349 DOI: 10.1002/Hep.27013 |
0.395 |
|
| 2014 |
Wojcik G, Latanich R, Mosbruger T, Astemborski J, Kirk GD, Mehta SH, Goedert JJ, Kim AY, Seaberg EC, Busch M, Thomas DL, Duggal P, Thio CL. Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans. The Journal of Infectious Diseases. 209: 355-9. PMID 23964107 DOI: 10.1093/Infdis/Jit444 |
0.388 |
|
| 2014 |
Aka PV, Kuniholm MH, Pfeiffer RM, Wang AS, Tang W, Chen S, Astemborski J, Plankey M, Villacres MC, Peters MG, Desai S, Seaberg EC, Edlin BR, Strickler HD, Thomas DL, et al. Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus. The Journal of Infectious Diseases. 209: 350-4. PMID 23956438 DOI: 10.1093/Infdis/Jit433 |
0.356 |
|
| 2014 |
Sherman KE, Thomas D, Chung RT. Human immunodeficiency virus and liver disease forum 2012. Hepatology (Baltimore, Md.). 59: 307-17. PMID 23904401 DOI: 10.1002/Hep.26638 |
0.41 |
|
| 2014 |
Schmidt WN, Nelson DR, Pawlotsky JM, Sherman KE, Thomas DL, Chung RT. Direct-acting antiviral agents and the path to interferon independence. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 12: 728-37. PMID 23872239 DOI: 10.1016/J.Cgh.2013.06.024 |
0.392 |
|
| 2014 |
Fischer WA, Drummond MB, Merlo CA, Thomas DL, Brown R, Mehta SH, Wise RA, Kirk GD. Hepatitis C virus infection is not an independent risk factor for obstructive lung disease. Copd. 11: 10-6. PMID 23862666 DOI: 10.3109/15412555.2013.800854 |
0.407 |
|
| 2013 |
Afdhal NH, Zeuzem S, Schooley RT, Thomas DL, Ward JW, Litwin AH, Razavi H, Castera L, Poynard T, Muir A, Mehta SH, Dee L, Graham C, Church DR, Talal AH, et al. The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. Journal of Viral Hepatitis. 20: 745-60. PMID 24168254 DOI: 10.1111/Jvh.12173 |
0.379 |
|
| 2013 |
Mullis CE, Laeyendecker O, Reynolds SJ, Ocama P, Quinn J, Boaz I, Gray RH, Kirk GD, Thomas DL, Quinn TC, Stabinski L. High frequency of false-positive hepatitis C virus enzyme-linked immunosorbent assay in Rakai, Uganda. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 1747-50. PMID 24051866 DOI: 10.1093/Cid/Cit602 |
0.388 |
|
| 2013 |
Kandathil AJ, Graw F, Quinn J, Hwang HS, Torbenson M, Perelson AS, Ray SC, Thomas DL, Ribeiro RM, Balagopal A. Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver. Gastroenterology. 145: 1404-13.e1-10. PMID 23973767 DOI: 10.1053/J.Gastro.2013.08.034 |
0.408 |
|
| 2013 |
Cox AL, Thomas DL. Hepatitis C virus vaccines among people who inject drugs. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: S46-50. PMID 23884065 DOI: 10.1093/Cid/Cit329 |
0.369 |
|
| 2013 |
Thomas DL. Global control of hepatitis C: where challenge meets opportunity. Nature Medicine. 19: 850-8. PMID 23836235 DOI: 10.1038/Nm.3184 |
0.365 |
|
| 2013 |
Osburn WO, Levine JS, Chattergoon MA, Thomas DL, Cox AL. Anti-inflammatory cytokines, pro-fibrogenic chemokines and persistence of acute HCV infection. Journal of Viral Hepatitis. 20: 404-13. PMID 23647957 DOI: 10.1111/Jvh.12052 |
0.348 |
|
| 2013 |
Kirk GD, Mehta SH, Astemborski J, Galai N, Washington J, Higgins Y, Balagopal A, Thomas DL. HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study. Annals of Internal Medicine. 158: 658-66. PMID 23440167 DOI: 10.7326/0003-4819-158-9-201305070-00604 |
0.312 |
|
| 2013 |
Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, ... ... Thomas DL, et al. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Annals of Internal Medicine. 158: 235-45. PMID 23420232 DOI: 10.7326/0003-4819-158-4-201302190-00003 |
0.378 |
|
| 2013 |
Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, ... ... Thomas DL, et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nature Genetics. 45: 164-71. PMID 23291588 DOI: 10.1038/Ng.2521 |
0.328 |
|
| 2013 |
El-Maouche D, Mehta SH, Sutcliffe CG, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT. Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection. Antiviral Therapy. 18: 237-42. PMID 22910231 DOI: 10.3851/Imp2264 |
0.331 |
|
| 2013 |
O'Brien T, Pfeiffer R, Kuniholm M, Muchmore B, Aka P, Tang W, Chen S, Wang A, Astemborski J, Bonkovsky H, Edlin B, Howell C, Morgan T, Sharp G, Strickler H, ... Thomas D, et al. 2 A FRAME-SHIFT VARIANT IN THE NOVEL IFNL4 GENE IS ASSOCIATED WITH IMPAIRED HCV CLEARANCE Journal of Hepatology. 58: S1-S2. DOI: 10.1016/S0168-8278(13)60004-5 |
0.34 |
|
| 2012 |
Thomas DL. Highly active anti-hepatitis C therapy: seven lessons from HIV. Antiviral Therapy. 17: 1183-8. PMID 23186629 DOI: 10.3851/Imp2429 |
0.393 |
|
| 2012 |
Nelson DR, Jensen DM, Sulkowski MS, Everson G, Fried MW, Gordon SC, Jacobson I, Reau NS, Sherman K, Terrault N, Thomas D. Hepatitis C virus: a critical appraisal of new approaches to therapy. Hepatitis Research and Treatment. 2012: 138302. PMID 23094146 DOI: 10.1155/2012/138302 |
0.368 |
|
| 2012 |
Limketkai BN, Mehta SH, Sutcliffe CG, Higgins YM, Torbenson MS, Brinkley SC, Moore RD, Thomas DL, Sulkowski MS. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. Jama. 308: 370-8. PMID 22820790 DOI: 10.1001/Jama.2012.7844 |
0.389 |
|
| 2012 |
Thomas D, Zoulim F. New challenges in viral hepatitis. Gut. i1-5. PMID 22504915 DOI: 10.1136/Gutjnl-2012-302122 |
0.371 |
|
| 2012 |
Vickerman P, Grebely J, Dore GJ, Sacks-Davis R, Page K, Thomas DL, Osburn WO, Cox AL, Aitken CK, Hickman M, Hellard M. The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design. The Journal of Infectious Diseases. 205: 1342-50. PMID 22457292 DOI: 10.1093/Infdis/Jis213 |
0.405 |
|
| 2012 |
Spaulding AC, Thomas DL. Screening for HCV infection in jails. Jama. 307: 1259-60. PMID 22453565 DOI: 10.1001/Jama.2012.374 |
0.407 |
|
| 2012 |
Mehta SH, Kirk GD, Astemborski J, Sulkowski MS, Afdhal NH, Thomas DL. Stability of liver fibrosis among HCV-infected injection drug users. Antiviral Therapy. 17: 813-21. PMID 22418880 DOI: 10.3851/Imp2085 |
0.384 |
|
| 2012 |
Munshaw S, Hwang HS, Torbenson M, Quinn J, Hansen KD, Astemborski J, Mehta SH, Ray SC, Thomas DL, Balagopal A. Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users. Hepatology (Baltimore, Md.). 56: 544-54. PMID 22331678 DOI: 10.1002/Hep.25655 |
0.405 |
|
| 2012 |
Liu L, Fisher BE, Thomas DL, Cox AL, Ray SC. Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution. Hepatology (Baltimore, Md.). 55: 1684-91. PMID 22234804 DOI: 10.1002/Hep.25575 |
0.399 |
|
| 2012 |
Thomas DL, Bartlett JG, Peters MG, Sherman KE, Sulkowski MS, Pham PA. Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 979-83. PMID 22173234 DOI: 10.1093/Cid/Cir882 |
0.42 |
|
| 2012 |
Ward JW, Lok AS, Thomas DL, El-Serag HB, Kim WR. Report on a single-topic conference on "Chronic viral hepatitis--strategies to improve effectiveness of screening and treatment". Hepatology (Baltimore, Md.). 55: 307-15. PMID 22105599 DOI: 10.1002/Hep.24797 |
0.371 |
|
| 2012 |
Walker Harris V, Sutcliffe CG, Araujo AB, Chiu GR, Travison TG, Mehta S, Sulkowski MS, Higgins Y, Thomas DL, Dobs AS, Beck TJ, Brown TT. Hip bone geometry in HIV/HCV-co-infected men and healthy controls. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 23: 1779-87. PMID 21901477 DOI: 10.1007/S00198-011-1769-9 |
0.35 |
|
| 2012 |
Thomas DL. 104 New Treatment of Hepatitis C Virus Infection Journal of Acquired Immune Deficiency Syndromes. 59: 41. DOI: 10.1097/01.Qai.0000413761.23126.Cd |
0.362 |
|
| 2011 |
Chattergoon MA, Levine JS, Latanich R, Osburn WO, Thomas DL, Cox AL. High plasma interleukin-18 levels mark the acute phase of hepatitis C virus infection. The Journal of Infectious Diseases. 204: 1730-40. PMID 21984735 DOI: 10.1093/Infdis/Jir642 |
0.363 |
|
| 2011 |
Kurbanov F, Abdel-Hamid M, Latanich R, Astemborski J, Mohamed M, Mikhail NM, El-Daly M, El-Kafrawy S, Thomas DL, Thio CL. Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort. The Journal of Infectious Diseases. 204: 1391-4. PMID 21933876 DOI: 10.1093/Infdis/Jir536 |
0.371 |
|
| 2011 |
Sherman KE, Thomas DL, Chung RT. Human immunodeficiency virus and liver disease forum 2010: conference proceedings. Hepatology (Baltimore, Md.). 54: 2245-53. PMID 21898501 DOI: 10.1002/Hep.24651 |
0.357 |
|
| 2011 |
Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md.). 54: 1433-44. PMID 21898493 DOI: 10.1002/Hep.24641 |
0.412 |
|
| 2011 |
Zeremski M, Dimova R, Astemborski J, Thomas DL, Talal AH. CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C. The Journal of Infectious Diseases. 204: 832-6. PMID 21849280 DOI: 10.1093/Infdis/Jir424 |
0.415 |
|
| 2011 |
Bacchetti P, Boylan R, Astemborski J, Shen H, Mehta SH, Thomas DL, Terrault NA, Monto A. Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis. Plos One. 6: e20104. PMID 21637766 DOI: 10.1371/Journal.Pone.0020104 |
0.34 |
|
| 2011 |
Stabinski L, Reynolds SJ, Ocama P, Laeyendecker O, Ndyanabo A, Kiggundu V, Boaz I, Gray RH, Wawer M, Thio C, Thomas DL, Quinn TC, Kirk GD. High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda. Antiviral Therapy. 16: 405-11. PMID 21555823 DOI: 10.3851/Imp1783 |
0.312 |
|
| 2011 |
Thomas DL, Leoutsakas D, Zabransky T, Kumar MS. Hepatitis C in HIV-infected individuals: cure and control, right now. Journal of the International Aids Society. 14: 22. PMID 21548988 DOI: 10.1186/1758-2652-14-22 |
0.4 |
|
| 2011 |
Stabinski L, Reynolds SJ, Ocama P, Laeyendecker O, Serwadda D, Gray RH, Wawer M, Thomas DL, Quinn TC, Kirk GD. Hepatitis B virus and sexual behavior in Rakai, Uganda. Journal of Medical Virology. 83: 796-800. PMID 21412787 DOI: 10.1002/Jmv.22051 |
0.346 |
|
| 2011 |
El-Maouche D, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS, Brown TT. Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. Journal of Hepatology. 55: 770-6. PMID 21338640 DOI: 10.1016/J.Jhep.2011.01.035 |
0.346 |
|
| 2011 |
Mehta SH, Astemborski J, Kirk GD, Strathdee SA, Nelson KE, Vlahov D, Thomas DL. Changes in blood-borne infection risk among injection drug users. The Journal of Infectious Diseases. 203: 587-94. PMID 21282191 DOI: 10.1093/Infdis/Jiq112 |
0.368 |
|
| 2011 |
Afdhal NH, McHutchison JG, Zeuzem S, Mangia A, Pawlotsky JM, Murray JS, Shianna KV, Tanaka Y, Thomas DL, Booth DR, Goldstein DB. Hepatitis C pharmacogenetics: state of the art in 2010. Hepatology (Baltimore, Md.). 53: 336-45. PMID 21254181 DOI: 10.1002/Hep.24052 |
0.394 |
|
| 2011 |
Drumright LN, Hagan H, Thomas DL, Latka MH, Golub ET, Garfein RS, Clapp JD, Campbell JV, Bonner S, Kapadia F, Thiel TK, Strathdee SA. Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention. Journal of Hepatology. 55: 45-52. PMID 21145862 DOI: 10.1016/J.Jhep.2010.10.028 |
0.353 |
|
| 2011 |
Woreta TA, Sutcliffe CG, Mehta SH, Brown TT, Higgins Y, Thomas DL, Torbenson MS, Moore RD, Sulkowski MS. Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus. Gastroenterology. 140: 809-17. PMID 21134375 DOI: 10.1053/J.Gastro.2010.11.052 |
0.388 |
|
| 2011 |
Salgado M, Kirk GD, Cox A, Rutebemberwa A, Higgins Y, Astemborski J, Thomas DL, Thio CL, Sulkowski MS, Blankson JN. Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African-American elite controllers/suppressors. Aids (London, England). 25: 385-7. PMID 21099664 DOI: 10.1097/Qad.0B013E328341B86A |
0.408 |
|
| 2011 |
Vu T, Sutcliff C, Mehta S, Higgins Y, Moore R, Thomas D, Sulkowski M. 1191 BASELINE LIVER STIFFNESS MEASURED BY TRANSIENT ELASTOGRAPHY IS INDEPENDENTLY ASSOCIATED WITH RISK OF END-STAGE LIVER DISEASE AND DEATH AMONG HIV/HCV CO-INFECTED ADULTS Journal of Hepatology. 54: S470. DOI: 10.1016/S0168-8278(11)61193-8 |
0.371 |
|
| 2011 |
Konerman M, Mehta SH, Sutcliffe CG, Vu T, Higgins YM, Torbenson M, Moore RD, Thomas DL, Sulkowski M. Rapid Fibrosis Progression Among HIV/Hepatitis C Virus (HCV) Coinfected Adults: Prospective Analysis of 446 Liver Biopsy Pairs Gastroenterology. 140: S-968-S-969. DOI: 10.1016/S0016-5085(11)64009-2 |
0.398 |
|
| 2010 |
Ocama P, Castelnuovo B, Kamya MR, Kirk GD, Reynolds SJ, Kiragga A, Colebunders R, Thomas DL. Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda. International Journal of Std & Aids. 21: 553-7. PMID 20975087 DOI: 10.1258/Ijsa.2010.010027 |
0.336 |
|
| 2010 |
Thomas DL. Curing hepatitis C with pills: a step toward global control. Lancet (London, England). 376: 1441-2. PMID 20951421 DOI: 10.1016/S0140-6736(10)61497-3 |
0.411 |
|
| 2010 |
Balagopal A, Thomas DL, Thio CL. IL28B and the control of hepatitis C virus infection. Gastroenterology. 139: 1865-76. PMID 20950615 DOI: 10.1053/J.Gastro.2010.10.004 |
0.38 |
|
| 2010 |
Seremba E, Ocama P, Opio CK, Thomas DL, Yuan HJ, Attar N, Lee WM. Poor performance of hepatitis C antibody tests in hospital patients in Uganda Journal of Medical Virology. 82: 1371-1378. PMID 20572078 DOI: 10.1002/Jmv.21817 |
0.371 |
|
| 2010 |
Seremba E, Ocama P, Opio CK, Kagimu M, Yuan HJ, Attar N, Thomas DL, Lee WM. Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda Journal of Medical Virology. 82: 1334-1340. PMID 20572076 DOI: 10.1002/Jmv.21813 |
0.308 |
|
| 2010 |
Mosbruger TL, Duggal P, Goedert JJ, Kirk GD, Hoots WK, Tobler LH, Busch M, Peters MG, Rosen HR, Thomas DL, Thio CL. Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus. The Journal of Infectious Diseases. 201: 1371-80. PMID 20331378 DOI: 10.1086/651606 |
0.374 |
|
| 2010 |
Brown TT, Mehta SH, Sutcliffe C, Higgins Y, Torbenson MS, Moore RD, Thomas DL, Sulkowski MS. Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons. Aids (London, England). 24: 811-7. PMID 20186036 DOI: 10.1097/Qad.0B013E3283333651 |
0.369 |
|
| 2010 |
Thio CL, Thomas DL. Interleukin-28b: A Key Piece of the Hepatitis C Virus Recovery Puzzle Gastroenterology. 138: 1240-1243. PMID 20184973 DOI: 10.1053/J.Gastro.2010.02.033 |
0.401 |
|
| 2010 |
Osburn WO, Fisher BE, Dowd KA, Urban G, Liu L, Ray SC, Thomas DL, Cox AL. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology. 138: 315-24. PMID 19782080 DOI: 10.1053/J.Gastro.2009.09.017 |
0.404 |
|
| 2009 |
Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 461: 798-801. PMID 19759533 DOI: 10.1038/Nature08463 |
0.418 |
|
| 2009 |
Grebely J, Thomas DL, Dore GJ. HCV reinfection studies and the door to vaccine development. Journal of Hepatology. 51: 628-31. PMID 19660823 DOI: 10.1016/J.Jhep.2009.07.002 |
0.391 |
|
| 2009 |
Sebastiani G, Halfon P, Castera L, Pol S, Thomas DL, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Guido M, Bourliere M, Noventa F, Alberti A. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology (Baltimore, Md.). 49: 1821-7. PMID 19291784 DOI: 10.1002/Hep.22859 |
0.32 |
|
| 2009 |
Kirk GD, Astemborski J, Mehta SH, Spoler C, Fisher C, Allen D, Higgins Y, Moore RD, Afdhal N, Torbenson M, Sulkowski M, Thomas DL. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 963-72. PMID 19236273 DOI: 10.1086/597350 |
0.419 |
|
| 2009 |
Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. Journal of Hepatology. 50: 36-41. PMID 19012989 DOI: 10.1016/J.Jhep.2008.07.039 |
0.36 |
|
| 2008 |
Thio CL, Astemborski J, Thomas R, Mosbruger T, Witt MD, Goedert JJ, Hoots K, Winkler C, Thomas DL, Carrington M. Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B. Journal of Immunology (Baltimore, Md. : 1950). 181: 7944-7. PMID 19017985 DOI: 10.4049/Jimmunol.181.11.7944 |
0.353 |
|
| 2008 |
Blankson JN, Klinzman D, Astemborski J, Thomas DL, Kirk GD, Stapleton JT. Low frequency of GB virus C viremia in a cohort of HIV-1-infected elite suppressors. Aids (London, England). 22: 2398-400. PMID 18981782 DOI: 10.1097/Qad.0B013E328316C3Fb |
0.337 |
|
| 2008 |
Dowd KA, Hershow RC, Yawetz S, Larussa P, Diaz C, Landesman SH, Paul ME, Read JS, Lu M, Thomas DL, Netski DM, Ray SC. Maternal neutralizing antibody and transmission of hepatitis C virus to infants. The Journal of Infectious Diseases. 198: 1651-5. PMID 18928374 DOI: 10.1086/593067 |
0.39 |
|
| 2008 |
Pandey JP, Namboodiri AM, Luo Y, Wu Y, Elston RC, Thomas DL, Rosen HR, Goedert JJ. Genetic markers of IgG influence the outcome of infection with hepatitis C virus. The Journal of Infectious Diseases. 198: 1334-6. PMID 18855559 DOI: 10.1086/592282 |
0.405 |
|
| 2008 |
Micchelli ST, Thomas D, Boitnott JK, Torbenson M. Hepatic giant cells in hepatitis C virus (HCV) mono-infection and HCV/HIV co-infection Journal of Clinical Pathology. 61: 1058-1061. PMID 18682418 DOI: 10.1136/Jcp.2008.058560 |
0.414 |
|
| 2008 |
Balagopal A, Philp FH, Astemborski J, Block TM, Mehta A, Long R, Kirk GD, Mehta SH, Cox AL, Thomas DL, Ray SC. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology. 135: 226-33. PMID 18457674 DOI: 10.1053/J.Gastro.2008.03.022 |
0.335 |
|
| 2008 |
Vivekanandan P, Kannangai R, Ray SC, Thomas DL, Torbenson M. Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 1227-36. PMID 18444860 DOI: 10.1086/529437 |
0.346 |
|
| 2008 |
Pandey JP, Luo Y, Elston RC, Wu Y, Philp FH, Astemborski J, Thomas DL, Netski DM. Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2. Human Immunology. 69: 158-64. PMID 18396207 DOI: 10.1016/J.Humimm.2008.01.019 |
0.382 |
|
| 2008 |
Thomas DL. The challenge of hepatitis C in the HIV-infected person Annual Review of Medicine. 59: 473-485. PMID 18186707 DOI: 10.1146/Annurev.Med.59.081906.081110 |
0.398 |
|
| 2008 |
Mehta SH, Genberg BL, Astemborski J, Kavasery R, Kirk GD, Vlahov D, Strathdee SA, Thomas DL. Limited uptake of hepatitis C treatment among injection drug users. Journal of Community Health. 33: 126-33. PMID 18165889 DOI: 10.1007/S10900-007-9083-3 |
0.375 |
|
| 2007 |
Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults. Aids (London, England). 21: 2209-16. PMID 18090048 DOI: 10.1097/Qad.0B013E3282F10De9 |
0.409 |
|
| 2007 |
Shmueli K, Thomas DL, Ordidge RJ. Design, construction and evaluation of an anthropomorphic head phantom with realistic susceptibility artifacts. Journal of Magnetic Resonance Imaging : Jmri. 26: 202-7. PMID 17659546 DOI: 10.1002/Jmri.20993 |
0.627 |
|
| 2007 |
Ticehurst JR, Hamzeh FM, Thomas DL. Factors affecting serum concentrations of hepatitis C virus (HCV) RNA in HCV genotype 1-infected patients with chronic hepatitis. Journal of Clinical Microbiology. 45: 2426-33. PMID 17537941 DOI: 10.1128/Jcm.02448-06 |
0.386 |
|
| 2007 |
Kannangai R, Vivekanandan P, Netski D, Mehta S, Kirk GD, Thomas DL, Torbenson M. Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 39: 101-5. PMID 17452002 DOI: 10.1016/J.Jcv.2007.03.006 |
0.346 |
|
| 2007 |
Wang XH, Netski DM, Astemborski J, Mehta SH, Torbenson MS, Thomas DL, Ray SC. Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution. Journal of Virology. 81: 6513-22. PMID 17329332 DOI: 10.1128/Jvi.02276-06 |
0.409 |
|
| 2007 |
Netski DM, Mosbruger T, Astemborski J, Mehta SH, Thomas DL, Cox AL. CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection. The Journal of Infectious Diseases. 195: 857-63. PMID 17299716 DOI: 10.1086/511826 |
0.42 |
|
| 2007 |
Huang Y, Yang H, Borg BB, Su X, Rhodes SL, Yang K, Tong X, Tang G, Howell CD, Rosen HR, Thio CL, Thomas DL, Alter HJ, Sapp RK, Liang TJ. A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection. Proceedings of the National Academy of Sciences of the United States of America. 104: 985-90. PMID 17215375 DOI: 10.1073/Pnas.0609954104 |
0.392 |
|
| 2007 |
Kapadia F, Latka MH, Hagan H, Golub ET, Campbell JV, Coady MH, Garfein RS, Thomas DL, Bonner S, Thiel T, Strathdee SA. Design and feasibility of a randomized behavioral intervention to reduce distributive injection risk and improve health-care access among hepatitis C virus positive injection drug users: the Study to Reduce Intravenous Exposures (STRIVE). Journal of Urban Health : Bulletin of the New York Academy of Medicine. 84: 99-115. PMID 17200799 DOI: 10.1007/S11524-006-9133-7 |
0.374 |
|
| 2007 |
Huang Y, Yang H, Borg BB, Su X, Rhodes SL, Yang K, Tong X, Tang G, Howell CD, Rosen HR, Thio CL, Thomas DL, Alter HJ, Sapp RK, Liang TJ. Erratum: A functional SNP of interferon-γ gene is important for interferon-α-induced and spontaneous recovery from hepatitis C virus infection (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, (985-990) DOI: 10.1073/pnas.0609954104) Proceedings of the National Academy of Sciences of the United States of America. 104. DOI: 10.1073/Pnas.0701153104 |
0.325 |
|
| 2006 |
Mehta SH, Lucas GM, Mirel LB, Torbenson M, Higgins Y, Moore RD, Thomas DL, Sulkowski MS. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. Aids (London, England). 20: 2361-9. PMID 17117023 DOI: 10.1097/Qad.0B013E32801086Da |
0.365 |
|
| 2006 |
Thio CL, Astemborski J, Bashirova A, Mosbruger T, Greer S, Witt MD, Goedert JJ, Hilgartner M, Majeske A, O'Brien SJ, Thomas DL, Carrington M. Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence. Journal of Virology. 81: 441-5. PMID 17079285 DOI: 10.1128/Jvi.01897-06 |
0.362 |
|
| 2006 |
Kuo I, ul-Hasan S, Galai N, Thomas DL, Zafar TA, Ahmed MA, Strathdee SA. High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan Harm Reduction Journal. 3: 26-26. PMID 16914042 DOI: 10.1186/1477-7517-3-26 |
0.324 |
|
| 2006 |
Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak MH, Srirak N, Vongchak T, Kawichai S, Thomas D, Sripaipan T, Netski D, Ananthakrishnan A, Nelson KE. Hepatitis C infection among drug users in northern Thailand. The American Journal of Tropical Medicine and Hygiene. 74: 1111-6. PMID 16760529 DOI: 10.4269/Ajtmh.2006.74.1111 |
0.395 |
|
| 2006 |
Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology (Baltimore, Md.). 43: 1317-25. PMID 16729309 DOI: 10.1002/Hep.21178 |
0.372 |
|
| 2006 |
Thomas DL. Acute hepatitis C: A window of opportunity Clinical Infectious Diseases. 42: 1671-1673. PMID 16705569 DOI: 10.1086/504333 |
0.4 |
|
| 2006 |
Fishbein DA, Lo Y, Netski D, Thomas DL, Klein RS. Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 41: 471-6. PMID 16652056 DOI: 10.1097/01.Qai.0000218360.28712.F3 |
0.382 |
|
| 2006 |
Walters KA, Smith MW, Pal S, Thompson JC, Thomas MJ, Yeh MM, Thomas DL, Fitzgibbon M, Proll S, Fausto N, Gretch DR, Carithers RL, Shuhart MC, Katze MG. Identification of a specific gene expression pattern associated with HCV-induced pathogenesis in HCV- and HCV/HIV-infected individuals. Virology. 350: 453-64. PMID 16574185 DOI: 10.1016/J.Virol.2006.02.030 |
0.386 |
|
| 2006 |
Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL. Progression of liver fibrosis among injection drug users with chronic hepatitis C. Hepatology (Baltimore, Md.). 43: 788-95. PMID 16557548 DOI: 10.1002/Hep.21091 |
0.375 |
|
| 2006 |
Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells Proceedings of the National Academy of Sciences of the United States of America. 103: 2310-2315. PMID 16461899 DOI: 10.1073/Pnas.0510727103 |
0.366 |
|
| 2006 |
Thomas DL. Growing importance of liver disease in HIV-infected persons Hepatology. 43. PMID 16447263 DOI: 10.1002/Hep.21033 |
0.348 |
|
| 2006 |
Smith MW, Walters KA, Korth MJ, Fitzgibbon M, Proll S, Thompson JC, Yeh MM, Shuhart MC, Furlong JC, Cox PP, Thomas DL, Phillips JD, Kushner JP, Fausto N, Carithers RL, et al. Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. Gastroenterology. 130: 179-87. PMID 16401481 DOI: 10.1053/J.Gastro.2005.08.015 |
0.343 |
|
| 2006 |
Thomas DL. Options for treatment of hepatitis C in HIV-infected persons Journal of Hepatology. 44. PMID 16356578 DOI: 10.1016/J.Jhep.2005.11.011 |
0.386 |
|
| 2006 |
Campbell JV, Hagan H, Latka MH, Garfein RS, Golub ET, Coady MH, Thomas DL, Strathdee SA. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug and Alcohol Dependence. 81: 259-65. PMID 16129567 DOI: 10.1016/J.Drugalcdep.2005.07.005 |
0.357 |
|
| 2005 |
Sulkowski MS, Thomas DL. Perspectives on HIV/hepatitis C virus co-infection, illicit drug use and mental illness Aids. 19. PMID 16251833 DOI: 10.1097/01.Aids.0000192064.09281.48 |
0.34 |
|
| 2005 |
Mehta SH, Thomas DL, Sulkowski MS, Safaein M, Vlahov D, Strathdee SA. A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users Aids. 19. PMID 16251816 DOI: 10.1097/01.Aids.0000192088.72055.90 |
0.41 |
|
| 2005 |
Thio CL, Sulkowski MS, Thomas DL. Treatment of chronic hepatitis B in HIV-infected persons: thinking outside the black box. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: 1035-40. PMID 16142671 DOI: 10.1086/496921 |
0.35 |
|
| 2005 |
Howe CJ, Fuller CM, Ompad DC, Galea S, Koblin B, Thomas D, Vlahov D. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug and Alcohol Dependence. 79: 389-95. PMID 16102381 DOI: 10.1016/J.Drugalcdep.2005.03.004 |
0.388 |
|
| 2005 |
Netski DM, Mosbruger T, Depla E, Maertens G, Ray SC, Hamilton RG, Roundtree S, Thomas DL, McKeating J, Cox A. Humoral immune response in acute hepatitis C virus infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: 667-75. PMID 16080089 DOI: 10.1086/432478 |
0.372 |
|
| 2005 |
Thomas DL, Seeff LB. Natural history of hepatitis C Clinics in Liver Disease. 9: 383-398. PMID 16023972 DOI: 10.1016/J.Cld.2005.05.003 |
0.351 |
|
| 2005 |
Thio CL, Mosbruger T, Astemborski J, Greer S, Kirk GD, O'Brien SJ, Thomas DL. Mannose binding lectin genotypes influence recovery from hepatitis B virus infection. Journal of Virology. 79: 9192-6. PMID 15994813 DOI: 10.1128/Jvi.79.14.9192-9196.2005 |
0.348 |
|
| 2005 |
Cox AL, Mosbruger T, Lauer GM, Pardoll D, Thomas DL, Ray SC. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology (Baltimore, Md.). 42: 104-12. PMID 15962289 DOI: 10.1002/Hep.20749 |
0.382 |
|
| 2005 |
Mehta SH, Netski D, Sulkowski MS, Strathdee SA, Vlahov D, Thomas DL. Liver enzyme values in injection drug users with chronic hepatitis C Digestive and Liver Disease. 37: 674-680. PMID 15951255 DOI: 10.1016/J.Dld.2005.03.009 |
0.381 |
|
| 2005 |
Ray SC, Fanning L, Wang XH, Netski DM, Kenny-Walsh E, Thomas DL. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. The Journal of Experimental Medicine. 201: 1753-9. PMID 15939791 DOI: 10.1084/Jem.20050122 |
0.382 |
|
| 2005 |
Cox AL, Mosbruger T, Mao Q, Liu Z, Wang XH, Yang HC, Sidney J, Sette A, Pardoll D, Thomas DL, Ray SC. Cellular immune selection with hepatitis C virus persistence in humans. The Journal of Experimental Medicine. 201: 1741-52. PMID 15939790 DOI: 10.1084/Jem.20050121 |
0.371 |
|
| 2005 |
Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, Thomas DL, Moore RE, Afdhal NH. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. Journal of Hepatology. 43: 78-84. PMID 15894397 DOI: 10.1016/J.Jhep.2005.02.025 |
0.404 |
|
| 2005 |
Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D, Vlahov D, Chien D, Shyamala V, Ray SC, Thomas DL. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 951-8. PMID 15824985 DOI: 10.1086/428578 |
0.411 |
|
| 2005 |
Oleksyk TK, Thio CL, Truelove AL, Goedert JJ, Donfield SM, Kirk GD, Thomas DL, O'Brien SJ, Smith MW. Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance. Genes and Immunity. 6: 347-57. PMID 15815689 DOI: 10.1038/Sj.Gene.6364188 |
0.325 |
|
| 2005 |
Sulkowski MS, Mehta SH, Torbenson M, Afdhal NH, Mirel L, Moore RD, Thomas DL. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. Aids (London, England). 19: 585-92. PMID 15802977 DOI: 10.1097/01.Aids.0000163935.99401.25 |
0.405 |
|
| 2005 |
Strathdee SA, Latka M, Campbell J, O'Driscoll PT, Golub ET, Kapadia F, Pollini RA, Garfein RS, Thomas DL, Hagan H. Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users Clinical Infectious Diseases. 40. PMID 15768339 DOI: 10.1086/427445 |
0.412 |
|
| 2005 |
Sulkowski MS, Thomas DL. Epidemiology and natural history of hepatitis C virus infection in injection drug users: Implications for treatment Clinical Infectious Diseases. 40. PMID 15768333 DOI: 10.1086/427440 |
0.404 |
|
| 2005 |
Hershow RC, O'Driscoll PT, Handelsman E, Pitt J, Hillyer G, Serchuck L, Lu M, Chen KT, Yawetz S, Pacheco S, Davenny K, Adeniyi-Jones S, Thomas DL. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 859-67. PMID 15736020 DOI: 10.1086/428121 |
0.359 |
|
| 2005 |
Dore GJ, Thomas DL. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection Seminars in Liver Disease. 25: 18-32. PMID 15731995 DOI: 10.1055/S-2005-864779 |
0.383 |
|
| 2005 |
Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection. Hepatology (Baltimore, Md.). 41: 123-31. PMID 15619237 DOI: 10.1002/Hep.20541 |
0.372 |
|
| 2005 |
Thio CL, Goedert JJ, Mosbruger T, Vlahov D, Strathdee SA, O'Brien SJ, Astemborski J, Thomas DL. An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection. Genes and Immunity. 5: 294-300. PMID 15071492 DOI: 10.1038/Sj.Gene.6364072 |
0.355 |
|
| 2005 |
Thio CL, Sulkowski M, Thomas DL. Erratum: Treatment of chronic hepatitis B in HIV-infected persons: Thinking outside of the black box (Clinical Infectious Diseases (October 1, 2005) 41 (1035-1040)) Clinical Infectious Diseases. 41. DOI: 10.1086/498088 |
0.34 |
|
| 2004 |
Sulkowski MS, Mehta SH, Chaisson RE, Thomas DL, Moore RD. Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir. Aids (London, England). 18: 2277-84. PMID 15577540 DOI: 10.1097/00002030-200411190-00008 |
0.308 |
|
| 2004 |
Alter MJ, Seeff LB, Bacon BR, Thomas DL, Rigsby MO, Di Bisceglie AM. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Annals of Internal Medicine. 141: 715-7. PMID 15520428 DOI: 10.7326/0003-4819-141-9-200411020-00013 |
0.407 |
|
| 2004 |
Dezzutti CS, Astemborski J, Thomas DL, Marshall JH, Cabrera T, Purdy M, Vlahov D, Garfein RS. Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 31: 210-4. PMID 15465414 DOI: 10.1016/J.Jcv.2004.03.014 |
0.393 |
|
| 2004 |
Thio CL, Mosbruger TL, Kaslow RA, Karp CL, Strathdee SA, Vlahov D, O'Brien SJ, Astemborski J, Thomas DL. Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. Journal of Virology. 78: 11258-62. PMID 15452244 DOI: 10.1128/Jvi.78.20.11258-11262.2004 |
0.326 |
|
| 2004 |
Thaikruea L, Thongsawat S, Maneekarn N, Netski D, Thomas DL, Nelson KE. Risk factors for hepatitis C virus infection among blood donors in northern Thailand. Transfusion. 44: 1433-40. PMID 15383015 DOI: 10.1111/J.1537-2995.2004.04073.X |
0.397 |
|
| 2004 |
Liu Z, Netski DM, Mao Q, Laeyendecker O, Ticehurst JR, Wang XH, Thomas DL, Ray SC. Accurate representation of the hepatitis C virus quasispecies in 5.2-kilobase amplicons. Journal of Clinical Microbiology. 42: 4223-9. PMID 15365015 DOI: 10.1128/Jcm.42.9.4223-4229.2004 |
0.395 |
|
| 2004 |
Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, ... ... Thomas DL, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (New York, N.Y.). 305: 872-4. PMID 15297676 DOI: 10.1126/Science.1097670 |
0.365 |
|
| 2004 |
Kannangai R, Molmenti E, Arrazola L, Klein A, Choti M, Thomas DL, Torbenson M. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. Journal of Viral Hepatitis. 11: 297-301. PMID 15230851 DOI: 10.1111/J.1365-2893.2004.00502.X |
0.326 |
|
| 2004 |
Golub ET, Latka M, Hagan H, Havens JR, Hudson SM, Kapadia F, Campbell JV, Garfein RS, Thomas DL, Strathdee SA. Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 81: 278-90. PMID 15136661 DOI: 10.1093/Jurban/Jth114 |
0.337 |
|
| 2004 |
Pandey JP, Astemborski J, Thomas DL. Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus. Journal of Virology. 78: 4561-5. PMID 15078937 DOI: 10.1128/Jvi.78.9.4561-4565.2004 |
0.394 |
|
| 2004 |
Netski DM, Wang XH, Mehta SH, Nelson K, Celentano D, Thongsawat S, Maneekarn N, Suriyanon V, Jittiwutikorn J, Thomas DL, Ticehurst JR. Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users. Journal of Clinical Microbiology. 42: 1631-6. PMID 15071017 DOI: 10.1128/Jcm.42.4.1631-1636.2004 |
0.379 |
|
| 2004 |
Thio CL, Netski DM, Myung J, Seaberg EC, Thomas DL. Changes in hepatitis B virus DNA levels with acute HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 38: 1024-9. PMID 15034837 DOI: 10.1086/382534 |
0.327 |
|
| 2004 |
Karacki PS, Gao X, Thio CL, Thomas DL, Goedert JJ, Vlahov D, Kaslow RA, Strathdee S, Hilgartner MW, O'Brien SJ, Carrington M. MICA and recovery from hepatitis C virus and hepatitis B virus infections Genes and Immunity. 5: 261-266. PMID 15029237 DOI: 10.1038/Sj.Gene.6364065 |
0.411 |
|
| 2004 |
Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology (Baltimore, Md.). 39: 51-7. PMID 14752822 DOI: 10.1002/Hep.20025 |
0.362 |
|
| 2004 |
Lanford RE, Guerra B, Chavez D, Bigger C, Brasky KM, Wang XH, Ray SC, Thomas DL. Cross-genotype immunity to hepatitis C virus. Journal of Virology. 78: 1575-81. PMID 14722311 DOI: 10.1128/Jvi.78.3.1575-1581.2004 |
0.38 |
|
| 2003 |
Augenbraun M, Goedert JJ, Thomas D, Feldman J, Seaberg EC, French AL, Robison E, Nowicki M, Terrault N. Incident Hepatitis C Virus in Women with Human Immunodeficiency Virus Infection Clinical Infectious Diseases. 37: 1357-1364. PMID 14583870 DOI: 10.1086/379075 |
0.397 |
|
| 2003 |
De Vita E, Thomas DL, Roberts S, Parkes HG, Turner R, Kinchesh P, Shmueli K, Yousry TA, Ordidge RJ. High resolution MRI of the brain at 4.7 Tesla using fast spin echo imaging. The British Journal of Radiology. 76: 631-7. PMID 14500278 DOI: 10.1259/Bjr/69317841 |
0.654 |
|
| 2003 |
Marx MA, Murugavel KG, Tarwater PM, SriKrishnan AK, Thomas DL, Solomon S, Celentano DD. Association of hepatitis C virus infection with sexual exposure in southern India. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 37: 514-20. PMID 12905135 DOI: 10.1086/376639 |
0.376 |
|
| 2003 |
Mehta SH, Moore RD, Thomas DL, Chaisson RE, Sulkowski MS. The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons. Journal of Acquired Immune Deficiency Syndromes (1999). 33: 577-84. PMID 12902801 DOI: 10.1097/00126334-200308150-00005 |
0.388 |
|
| 2003 |
Strasfeld L, Lo Y, Netski D, Thomas DL, Klein RS. The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 33: 356-64. PMID 12843747 DOI: 10.1097/00126334-200307010-00010 |
0.391 |
|
| 2003 |
Mehta SH, Brancati FL, Strathdee SA, Pankow JS, Netski D, Coresh J, Szklo M, Thomas DL. Hepatitis C virus infection and incident type 2 diabetes Hepatology. 38: 50-56. PMID 12829986 DOI: 10.1053/Jhep.2003.50291 |
0.345 |
|
| 2003 |
Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected patient Clinics in Liver Disease. 7: 179-194. PMID 12691466 DOI: 10.1016/S1089-3261(02)00074-0 |
0.388 |
|
| 2003 |
Marx MA, Murugavel KG, Sivaram S, Balakrishnan P, Steinhoff M, Anand S, Thomas DL, Solomon S, Celentano DD. The association of health-care use and hepatitis C virus infection in a random sample of urban slum community residents in southern India. The American Journal of Tropical Medicine and Hygiene. 68: 258-62. PMID 12641422 DOI: 10.4269/Ajtmh.2003.68.258 |
0.393 |
|
| 2003 |
Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person Annals of Internal Medicine. 138: 197-207. PMID 12558359 DOI: 10.7326/0003-4819-138-3-200302040-00012 |
0.404 |
|
| 2003 |
Goedert JJ, Charurat M, Blattner WA, Hershow RC, Pitt J, Diaz C, Mofenson LM, Green K, Minkoff H, Paul ME, Thomas DL, Whitby D. Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. Aids (London, England). 17: 425-33. PMID 12556697 DOI: 10.1097/00002030-200302140-00017 |
0.356 |
|
| 2003 |
THIO C, MOSBRUGER T, ASTEMBORSKI J, GOEDERT J, OBRIEN S, THOMAS D. 32 An analysis of single nucleotide polymorphismsand haplotypes with hepatitis C virus outcomes Hepatology. 38: 171-171. DOI: 10.1016/S0270-9139(03)80075-7 |
0.325 |
|
| 2002 |
Thio CL, Seaberg EC, Skolasky R, Phair J, Visscher B, Muñoz A, Thomas DL. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet (London, England). 360: 1921-6. PMID 12493258 DOI: 10.1016/S0140-6736(02)11913-1 |
0.339 |
|
| 2002 |
Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 35: 783-8. PMID 12228813 DOI: 10.1086/342063 |
0.39 |
|
| 2002 |
Mehta SH, Strathdee SA, Thomas DL. Association between hepatitis C virus infection and diabetes mellitus. Epidemiologic Reviews. 23: 302-12. PMID 12192739 DOI: 10.1093/Oxfordjournals.Epirev.A000808 |
0.384 |
|
| 2002 |
Torbenson M, Thomas DL. Occult hepatitis B Lancet Infectious Diseases. 2: 479-486. PMID 12150847 DOI: 10.1016/S1473-3099(02)00345-6 |
0.354 |
|
| 2002 |
Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. Jama. 288: 199-206. PMID 12095384 DOI: 10.1001/Jama.288.2.199 |
0.388 |
|
| 2002 |
Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, Strathdee SA, Vlahov D, Thomas DL. Protection against persistence of hepatitis C. Lancet (London, England). 359: 1478-83. PMID 11988247 DOI: 10.1016/S0140-6736(02)08435-0 |
0.389 |
|
| 2002 |
Sulkowski MS, Ray SC, Thomas DL. Needlestick transmission of hepatitis C. Jama. 287: 2406-13. PMID 11988061 DOI: 10.1001/Jama.287.18.2406 |
0.404 |
|
| 2002 |
Rai R, Wilson LE, Astemborski J, Anania F, Torbenson M, Spoler C, Vlahov D, Strathdee SA, Boitnott J, Nelson KE, Thomas DL. Severity and correlates of liver disease in hepatitis C virus-infected injection drug users. Hepatology (Baltimore, Md.). 35: 1247-55. PMID 11981775 DOI: 10.1053/Jhep.2002.33151 |
0.406 |
|
| 2002 |
Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Astemborski J, Carrington M, Thomas DL. HLA-Cw*04 and hepatitis C virus persistence. Journal of Virology. 76: 4792-7. PMID 11967296 DOI: 10.1128/Jvi.76.10.4792-4797.2002 |
0.356 |
|
| 2002 |
Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections Hepatology. 35: 182-189. PMID 11786975 DOI: 10.1053/Jhep.2002.30319 |
0.413 |
|
| 2002 |
Mehta SH, Cox AL, Strathdee SA, Vlahov D, Thomas DL. Immunity against hepatitis C virus infection The Lancet. 360: 1020-1021. DOI: 10.1016/S0140-6736(02)11104-4 |
0.356 |
|
| 2001 |
Thomas DL. Hepatitis C: Epidemiologic quandaries Clinics in Liver Disease. 5: 955-968. PMID 11685803 DOI: 10.1016/S1089-3261(05)70203-8 |
0.371 |
|
| 2001 |
Sadaphal P, Astemborski J, Graham NM, Sheely L, Bonds M, Madison A, Vlahov D, Thomas DL, Sterling TR. Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 33: 1687-91. PMID 11641824 DOI: 10.1086/323896 |
0.411 |
|
| 2001 |
Nelson KE, Thomas DL. Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections Clinical and Diagnostic Laboratory Immunology. 8: 867-870. PMID 11527794 DOI: 10.1128/Cdli.8.5.867-870.2001 |
0.417 |
|
| 2001 |
Thio CL, Thomas DL, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O'Brien SJ, Karacki P, Marti D, Astemborski J, Carrington M. Racial differences in HLA class II associations with hepatitis C virus outcomes. The Journal of Infectious Diseases. 184: 16-21. PMID 11398104 DOI: 10.1086/321005 |
0.339 |
|
| 2001 |
Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States [1] Hepatology. 33: 1554. PMID 11391549 DOI: 10.1053/Jhep.2001.0103306Le01 |
0.313 |
|
| 2001 |
Mao Q, Ray SC, Laeyendecker O, Ticehurst JR, Strathdee SA, Vlahov D, Thomas DL. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies Journal of Virology. 75: 3259-3267. PMID 11238852 DOI: 10.1128/Jvi.75.7.3259-3267.2001 |
0.401 |
|
| 2001 |
Thomas DL, Rich JD, Schuman P, Smith DK, Astemborski JA, Nolt KR, Klein RS. Multicenter evaluation of hepatitis C RNA levels among female injection drug users. The Journal of Infectious Diseases. 183: 973-6. PMID 11237816 DOI: 10.1086/319256 |
0.367 |
|
| 2001 |
Wong DK, Dudley DD, Dohrenwend PB, Lauer GM, Chung RT, Thomas DL, Walker BD. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. Journal of Virology. 75: 1229-35. PMID 11152496 DOI: 10.1128/Jvi.75.3.1229-1235.2001 |
0.421 |
|
| 2000 |
Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Annals of Internal Medicine. 133: 592-9. PMID 11033586 DOI: 10.7326/0003-4819-133-8-200010170-00009 |
0.364 |
|
| 2000 |
Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout egypt. The Journal of Infectious Diseases. 182: 698-707. PMID 10950762 DOI: 10.1086/315786 |
0.374 |
|
| 2000 |
Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D. The natural history of hepatitis C virus infection: host, viral, and environmental factors. Jama. 284: 450-6. PMID 10904508 DOI: 10.1001/Jama.284.4.450 |
0.396 |
|
| 2000 |
Abdel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, Thomas D, Fix AD, Strickland GT, Anwar W, Sallam I. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology (Baltimore, Md.). 32: 111-5. PMID 10869297 DOI: 10.1053/Jhep.2000.8438 |
0.394 |
|
| 2000 |
Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. S77-84. PMID 10770916 DOI: 10.1086/313842 |
0.425 |
|
| 2000 |
Thio CL, Thomas DL, Carrington M. Chronic viral hepatitis and the human genome Hepatology. 31: 819-827. PMID 10733534 DOI: 10.1053/He.2000.4316 |
0.381 |
|
| 2000 |
Thomas DL, Astemborski J, Vlahov D, Strathdee SA, Ray SC, Nelson KE, Galai N, Nolt KR, Laeyendecker O, Todd JA. Determinants of the quantity of hepatitis C virus RNA Journal of Infectious Diseases. 181: 844-851. PMID 10720503 DOI: 10.1086/315314 |
0.379 |
|
| 2000 |
Ray SC, Mao Q, Lanford RE, Bassett S, Laeyendecker O, Wang YM, Thomas DL. Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees Journal of Virology. 74: 3058-3066. PMID 10708420 DOI: 10.1128/Jvi.74.7.3058-3066.2000 |
0.357 |
|
| 2000 |
Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection Journal of the American Medical Association. 283: 74-80. PMID 10632283 DOI: 10.1001/Jama.283.1.74 |
0.37 |
|
| 2000 |
Thomas DL. Hepatitis C epidemiology Current Topics in Microbiology and Immunology. 242: 25-41. PMID 10592654 DOI: 10.1007/978-3-642-59605-6_2 |
0.394 |
|
| 2000 |
Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL. Screening for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Individuals Journal of Clinical Microbiology. 38: 575-577. DOI: 10.1128/Jcm.38.2.575-577.2000 |
0.402 |
|
| 2000 |
Sulkowski MS, Ball LM, Tice AD, Dieterich DT, Thomas DL. Antiviral efficacy and safety of ribavirin with daily versus TIW interferon a-2b for chronic HCV infection Gastroenterology. 118: A1492. DOI: 10.1016/S0016-5085(00)81871-5 |
0.365 |
|
| 1999 |
Labrique AB, Thomas DL, Stoszek SK, Nelson KE. Hepatitis E: an emerging infectious disease. Epidemiologic Reviews. 21: 162-79. PMID 10682255 DOI: 10.1093/Oxfordjournals.Epirev.A017994 |
0.304 |
|
| 1999 |
Zellos A, Thomas DL, Mocilnikar C, Perlman EJ, Boitnott JK, Casella JF, Schwarz KB. High viral load and mild liver injury in children with hemophilia compared with other children with chronic hepatitis C virus infection. Journal of Pediatric Gastroenterology and Nutrition. 29: 418-23. PMID 10512401 DOI: 10.1097/00005176-199910000-00009 |
0.395 |
|
| 1999 |
Ray SC, Wang YM, Laeyendecker O, Ticehurst JR, Villano SA, Thomas DL. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy Journal of Virology. 73: 2938-2946. PMID 10074143 DOI: 10.1128/Jvi.73.4.2938-2946.1999 |
0.366 |
|
| 1999 |
Thio CL, Carrington M, Marti D, O'Brien SJ, Vlahov D, Nelson KE, Astemborski J, Thomas DL. Class II HLA alleles and hepatitis B virus persistence in African Americans. The Journal of Infectious Diseases. 179: 1004-6. PMID 10068598 DOI: 10.1086/314684 |
0.301 |
|
| 1999 |
Inglesby TV, Rai R, Astemborski J, Gruskin L, Nelson KE, Vlahov D, Thomas DL. A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology (Baltimore, Md.). 29: 590-6. PMID 9918940 DOI: 10.1002/Hep.510290219 |
0.41 |
|
| 1999 |
Bassett SE, Thomas DL, Brasky KM, Lanford RE. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees Journal of Virology. 73: 1118-1126. PMID 9882313 DOI: 10.1128/Jvi.73.2.1118-1126.1999 |
0.327 |
|
| 1998 |
Wang YM, Ray SC, Laeyendecker O, Ticehurst JR, Thomas DL. Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single- and double-stranded DNAs Journal of Clinical Microbiology. 36: 2982-2989. PMID 9738054 DOI: 10.1128/Jcm.36.10.2982-2989.1998 |
0.348 |
|
| 1998 |
Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 18. PMID 9663618 DOI: 10.1097/00042560-199802001-00004 |
0.375 |
|
| 1998 |
Thomas DL, Villano SA, Riester KA, Hershow R, Mofenson LM, Landesman SH, Blaine Hollinger F, Davenny K, Riley L, Diaz C, Tang HB, Quinn TC. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers Journal of Infectious Diseases. 177: 1480-1488. PMID 9607823 DOI: 10.1086/515315 |
0.386 |
|
| 1998 |
Zellos A, Thomas D, Perlman E, Boitnott J, Schwarz KB. LIVER PATHOLOGY IN A COHORT OF HEPATITIS C VIRUS (HCV) INFECTED CHILDREN Journal of Pediatric Gastroenterology &Amp Nutrition. 26: 586. DOI: 10.1097/00005176-199805000-00211 |
0.402 |
|
| 1998 |
Rai R, Anania F, Boitnott J, Diehl A, Spoler C, Thomas D. Hepatic expression of interleukin-12 alters outcome in HCV-infected patients Gastroenterology. 114: A1325. DOI: 10.1016/S0016-5085(98)85379-1 |
0.385 |
|
| 1997 |
Villano SA, Nelson KE, Vlahov D, Purcell RH, Saah AJ, Thomas DL. Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 25: 726-8. PMID 9314468 DOI: 10.1086/513757 |
0.31 |
|
| 1997 |
Thomas DL, Nakatsuji Y, Shih JW, Alter HJ, Nelson KE, Astemborski JA, Lyles CM, Vlahov D. Persistence and clinical significance of hepatitis G virus infections in injecting drug users. The Journal of Infectious Diseases. 176: 586-92. PMID 9291303 DOI: 10.1086/514078 |
0.316 |
|
| 1997 |
Hershow RC, Riester KA, Lew J, Quinn TC, Mofenson LM, Davenny K, Landesman S, Cotton D, Celine Hanson I, Hillyer GV, Tang HB, Thomas DL. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers Journal of Infectious Diseases. 176: 414-420. PMID 9237706 DOI: 10.1086/514058 |
0.403 |
|
| 1997 |
Thomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ, Purcell RH. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. Journal of Clinical Microbiology. 35: 1244-7. PMID 9114415 DOI: 10.1128/Jcm.35.5.1244-1247.1997 |
0.357 |
|
| 1997 |
Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis New England Journal of Medicine. 336: 196-204. PMID 8988900 DOI: 10.1056/Nejm199701163360307 |
0.385 |
|
| 1997 |
Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal of Clinical Microbiology. 35: 3274-3277. DOI: 10.1128/Jcm.35.12.3274-3277.1997 |
0.383 |
|
| 1996 |
Miskovsky EP, Carrella AV, Gutekunst K, Sun CA, Quinn TC, Thomas DL. Clinical characterization of a competitive PCR assay for quantitative testing of hepatitis C virus. Journal of Clinical Microbiology. 34: 1975-9. PMID 8818893 DOI: 10.1128/Jcm.34.8.1975-1979.1996 |
0.379 |
|
| 1996 |
Thomas DL. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America American Journal of Medicine. 100: 41-45. PMID 8579085 DOI: 10.1016/S0002-9343(96)90009-1 |
0.408 |
|
| 1995 |
Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE. Correlates of hepatitis C virus infections among injection drug users. Medicine. 74: 212-20. PMID 7623656 DOI: 10.1097/00005792-199507000-00005 |
0.387 |
|
| 1995 |
Waked IA, Saleh SM, Moustafa MS, Raouf AA, Thomas DL, Strickland GT. High prevalence of hepatitis C in Egyptian patients with chronic liver disease Gut. 37: 105-107. PMID 7545630 DOI: 10.1136/Gut.37.1.105 |
0.358 |
|
| 1995 |
Thomas DL, Zenilman JM, Alter HJ, Shih JW, Galai N, Carella AV, Quinn TC. Sexual transmission of hepatitis c virus among patients attending sexually transmitted diseases clinics in baltimore-an analysis of 309 sex partnerships Journal of Infectious Diseases. 171: 768-775. PMID 7535827 DOI: 10.1093/Infdis/171.4.768 |
0.301 |
|
| 1994 |
Thomas DL, Cannon RO, Shapiro CN, Hook EW, Alter MJ, Quinn TC. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. The Journal of Infectious Diseases. 169: 990-5. PMID 8169429 DOI: 10.1093/Infdis/169.5.990 |
0.393 |
|
| 1994 |
Thomas DL, Quinn TC, Mahley RW, Palaoglu E, Badur S. The epidemiology of hepatitis C in Turkey. Infection. 22: 411-414. PMID 7698839 DOI: 10.1007/Bf01715499 |
0.395 |
|
| 1994 |
Thomas DL, Rompalo AM, Zenilman J, Hoover D, Hook EW, Quinn TC. Association of hepatitis c virus infection with false-positive tests for syphilis Journal of Infectious Diseases. 170: 1579-1581. PMID 7527828 DOI: 10.1093/Infdis/170.6.1579 |
0.375 |
|
| 1993 |
Coursaget P, Depril N, Yenen OS, Cavuslu S, Badur S, Thomas DL, Quinn TC. Hepatitis-E Virus-Infection In Turkey The Lancet. 342: 810-811. PMID 8103902 DOI: 10.1016/0140-6736(93)91578-A |
0.35 |
|
| 1993 |
Thomas DL, Mahley RW, Badur S, Palaoglu KE, Quinn TC. Epidemiology of hepatitis E virus infection in Turkey. Lancet (London, England). 341: 1561-2. PMID 8099641 DOI: 10.1016/0140-6736(93)90698-G |
0.35 |
|
| 1993 |
Thomas DL. Viral Hepatitis in Health Care Personnel at The Johns Hopkins Hospital Archives of Internal Medicine. 153: 1705. DOI: 10.1001/Archinte.1993.00410140095011 |
0.36 |
|
| Show low-probability matches. |